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Abstract
Objective: Increased maternal testosterone concentration during pregnancy may 
affect the fetus. Therefore it is clinically relevant to have a quick and reliable method 
to determine free testosterone levels. Current calculators for free testosterone are 
suspected to perform poorly during pregnancy due to suggested competition between 
high levels of estradiol and free (bio-active) testosterone for sex hormone-binding 
globulin (SHBG) binding. Therefore, it is claimed that reliable calculation of free 
testosterone concentration is not possible. However, recent evidence on SHBG-binding 
sites questions the estradiol effect on the testosterone-SHBG binding during pregnancy. 
In this study, we investigated whether the free testosterone concentration can be 
calculated in pregnant women.
Design and methods: Free testosterone was measured with a specially developed 
equilibrium dialysis method combined with liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Free testosterone was also calculated with the formulas of 
Vermeulen et al. and Ross et al.
Results: Total and free testosterone measured in healthy men and women were in 
good agreement with earlier reports. In pregnant women, total testosterone values 
were higher than in non-pregnant women, whereas free testosterone values were 
comparable. Calculated free testosterone levels in pregnant women were highly 
correlated, but marginally higher, compared to measured free testosterone levels.
Conclusions: We developed an equilibrium dialysis–LC-MS/MS method for the measurement 
of free testosterone in the low range of pregnant and non-pregnant women. Although 
during pregnancy total testosterone is increased, this is not the case for free testosterone. 
The free testosterone formulas perform well in pregnant women.
Introduction
In women, small amounts of testosterone are synthesized 
in the ovaries (1). Next to the gonads, testosterone is also 
produced and secreted from the adrenal glands in both 
sexes. Most testosterone circulates tightly bound to sex 
hormone-binding globulin (SHBG) or weakly bound 
to albumin, orosomucoid and corticosteroid-binding 
globulin (2). Only 1–4% circulates as free testosterone, 
which is considered to be the biologically active 
component (2, 3). Determination of free testosterone 
levels is important in the diagnosis of androgen deficiency 
in men (4) and androgen excess in women (i.e., polycystic 
ovary syndrome and hirsutism (5, 6)). During pregnancy 
increased maternal testosterone is associated with fetal 
growth restriction in utero (7, 8), it may perturb the 
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insulin–glucose homeostasis (9) and possibly leads to fetal 
virilization (10, 11).
Direct measurements of free testosterone by 
immunoassays have shown to give unreliable results (12, 
13, 14) and accurate measurements can only be performed 
with methods such as equilibrium dialysis, symmetric 
dialysis or ultrafiltration (3).
We developed a measurement method for free 
testosterone with equilibrium dialysis followed by 
liquid chromatography tandem mass spectrometry 
(ED-LC-MS/MS). LC-MS/MS enables the accurate, specific 
and matrix-independent measurement of testosterone 
with direct calibration. Equilibrium dialysis enables to 
separate the free- from protein-bound testosterone with 
minimal disturbance of the physiological equilibrium 
when performed under adequate conditions and may be 
suitable as the reference measurement procedure (2).
For daily routine use, however, ED-LC-MS/MS is 
inconvenient. Therefore formulas for calculating free 
testosterone from total testosterone and concentrations 
of its binding proteins SHBG and albumin concentrations 
have been developed which make quantification of free 
testosterone concentration easily accessible. The formulas 
that are based on law of mass action perform well in men 
and, even at low free testosterone concentrations, in 
women (12, 13).
In pregnancy, elevated maternal testosterone levels 
may affect the fetus. Therefore, it is important to have a 
reliable and quick method to determine free testosterone 
levels. The possible use of free testosterone calculation 
during pregnancy, when estradiol concentration is 
substantially increased, is debated as SHBG is also able to 
bind estradiol with similar binding affinity (3–4 times less 
than testosterone) (2, 13, 15, 16). Recently, evidence is 
found for differential binding of androgens and estrogens 
to SHBG (16) and dynamic regulation of the homodimeric 
SHBG-binding sites (2, 17, 18). In their review Goldman 
et al. (2) elegantly describe that the testosterone binding to 
SHBG is much better represented by a multistep dynamic 
model of allosteric regulation instead of the linear model 
used by Vermeulen et  al. (13), Sodergard et  al. (19) and 
Maher et al. (20). Since the assumed estradiol interference 
on the testosterone binding to SHBG utilizes the linear 
model, these new insights question this assumed estradiol 
interference.
To investigate this, free testosterone levels were 
measured with the state of the art method ED-LC-MS/MS 
in pregnant and in non-pregnant females to investigate 
whether the free testosterone concentration is different 
between these groups. Furthermore, total testosterone, 
SHBG and estradiol were measured in these groups to 
calculate free testosterone by the formula of Vermeulen 
et al. (13) and by Ross et al. (21) and to investigate whether 
or not calculation of free testosterone yields results 
differing from those obtained by ED-LC-MS/MS. This will 
answer the question whether free testosterone calculation 
may be used in pregnant females.
Materials and methods
Subjects
Serum samples for quantification of total and free 
testosterone concentration in pregnant women were 
derived from surplus anonymized material from women 
aged between 19 and 38 years attending the Slingeland 
Hospital (a large regional hospital) laboratory for the 
routine national antenatal screening. These included 
65 random samples taken in the first trimester (week 8 
till 13) and 37 random samples taken at the end of the 
second trimester (week 27 till week 28 + 6  days) from 
different pregnant women. For comparison total and free 
testosterone was determined using surplus anonymized 
random serum from 46 non-pregnant women (aged 
14–79  years) and for method validation purposes from 
47 men (age 14–81  years). These patients were referred 
to the same hospital laboratory by general practitioners 
for screening for allergy and/or auto-immune disease. 
All samples were stored at −20°C before measurement. 
Consent has been obtained from each patient or subject 
after full explanation of the purpose and nature of all 
procedures used. The study was approved by Ethics 
Committee of the Radboud University Nijmegen Medical 
Centre.
Materials
Measurement of free testosterone by equilibrium 
dialysis – LC-MS/MS
Equilibrium dialysis Serum was dialyzed in a multi-cell 
equilibrium dialyzer using Teflon dialyzing cells consist-
ing of two identical parts between which a flat mem-
brane is fitted (Dianorm-Geräte, Munic, Germany). The 
dialysis cells are incubated in a water bath with constant 
agitation by a rotating apparatus and temperature during 
dialysis was maintained at 37 ± 0.5°C, by constant moni-
toring with an immersion thermostatic system (Tinytag 
TGP-4020 logger and PB5001-1M5 sonde; Gemini data 
loggers). The dialysis membranes were prepared from 
Dianorm (Diachema dialysis membranes 10.14) with a 
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cut-off of 5 kDa. Equilibrium dialysis was performed for 
5 h with 1 mL serum against 1 mL HEPES buffer, while 
rotating the dialysis apparatus at 20 rpm.
The HEPES buffer used for equilibrium dialysis was 
composed to reflect the electrolyte composition and 
pH of serum and contained in addition to 12.570 g/L 
N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic 
acid (HEPES), 5.353 g/L NaCl, 0.200 g/L KCl, 0.224 g/L 
KH2PO4, 0.275 g/L MgSO4·7H2O, 0.300 g/L urea, 0.275 
g/L CaCl2·2H2O, 0.900 g/L NaOH, and 0.520 g/L NaN3 
(all from Merck). pH was adjusted with HCl to pH 7.40 
(at 37°C) (22). The buffer was diluted by ultrapure water 
produced with a Milli Advantage A10. The quality of the 
other solvents was gradient grade (methanol, 2-propanol, 
formic acid; Biosolve and ammonium hydroxide 
(28–30 wt%); Across).
To ensure a physiological pH of 7.40 ± 0.03 in the 
serum sample at 37.0°C, 100 µL of a concentrated HEPES 
buffer (8.8 g/L NaOH, HEPES and pH adjusted with HCl to 
pH 7.40 (at 37°C)) was added to the serum sample before 
dialysis. Experiments were performed to determine the 
influence of pH and temperature (22).
LC-MS/MS with solid phase extraction Testosterone 
in dialysate was analyzed by LC-MS/MS after solid phase 
extraction. An eight-point calibration series with testos-
terone (0.03–69 nmol/L) (Steraloids, purity >99%) was 
prepared, aliquoted (100 µL each) and stored at −40°C 
until analysis. In every run one aliquot per calibration 
point was used.
Internal standard (5 nmol/L) was added [13C3]-
Testosterone (Isoscience, King of Prussia, PA; purity 
>98%) to 500 µL dialysate with subsequent solid phase 
extraction using Oasis MCX 1cc cartridges (Waters 
Corp). Columns were pre-equilibrated with 1 mL 
methanol:isopropanol (95:5) and subsequently washed 
with 1 mL H2O. After application of 500 µL of the sample, 
columns were washed with 1 mL H2O:NH4OH (95:5) 
and 1 mL methanol:H2O:formic acid (20:78:2). The 
300 µL eluate (methanol) was dried under a stream of N2 
gas, reconstituted in 100 µL of methanol:H2O (30:70), 
thereby being concentrated five times. Of this 100 µL 
reconstituted sample 10 µL was injected and also per 
calibration point 10 µL from each aliquot was injected 
into an Agilent Technologies 1290 Infinity VL UHPLC-
system (Agilent Technologies) equipped with a BEH C18 
(1.7 μm 2.1 × 50 mm) analytical column (Waters Corp.) at 
60°C. Mobile phase A (methanol:water 20:80 + 2 mmol/L 
NH4CH3COO + 0.1% formic acid) and B (methanol:water 
98:2 + 2 mM NH4CH3COO + 0.1% formic acid) were run 
in a gradient (0.4 mL/min). The gradient program was 
as follows: start gradient 70:30 A:B for 2.5 min; then to 
60:40 A:B in 2 min; followed by a gradient in 2.5 min to 
35:65 and a subsequent gradient in 0.5 min to 2:98 to 
remain such for 0.5 min and thereafter to 70:30 A:B in 
0.5 min and remain such for 0.5 min. Retention time was 
4.3 min with a total run time of 9 min. An Agilent 6490 
tandem mass spectrometer (Agilent Technologies) was 
operated in the electrospray positive ion mode, with a 
capillary voltage 3.5 kV, fragmentor voltage 380 V, sheath 
gas temperature 350°C and gas temperature 150°C with 
N2 collision gas. The collision energy was optimized for all 
analytes. Two mass transitions were monitored for each 
analyte, and the internal standards. The first transition 
was used for quantification, the second for confirmation. 
The transitions (Q1 > Q3), collision energy (between 
brackets) and dwell time were m/z 289 > 97 (30 eV) and 
m/z 289 > 109 (30 eV) for TES (50 ms); m/z 292 > 100 
(30 eV) and m/z 292 > 112 (30 eV) for [13C3]-TES (50 ms).
Validation experiments The correlation coefficient (r) 
of each calibration curve had to be >0.995 and the signal-
to-noise ratio >10. Samples with known concentrations 
were measured in each run as internal quality controls.
Ion suppression was assessed by continuous infusion 
of the labeled steroid in a dialysate matrix. The abundance 
was compared between a dialysate matrix and mobile 
phase at the retention time of testosterone.
Total imprecision was assessed by an adapted CLSI 
EP5 protocol with pooled samples of free testosterone 
at three levels. Samples were dialyzed and measured by 
LC-MS/MS in duplicate in independent experiments 
(n = 10). Experiments were performed to investigate 
the lower limit of quantification (LOQ). The LOQ was 
defined as the free testosterone concentration with a 
total coefficient of variation (CV) of 10%, determined 
by repeated serum measurements of free testosterone in 
independent experiments and calculated by EP Evaluator. 
For the statistical processing of data, measurements 
below the LOQ were quantified when they had a signal 
to noise ratio of >10. Measurements with a signal to 
noise ratio <10 were quantified for statistical processing 
as 0,5* LOQ.
Recovery of testosterone was calculated from an 
addition experiment in dialysate (addition of 75, 100 and 
200 pmol/L from NIST SRM971). Method comparison 
was conducted with a validated symmetric dialysis – 
LC-MS/MS method.
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Measurement of free testosterone by symmetric 
dialysis – LC-MS/MS
Free testosterone in serum was measured by symmetric 
dialysis (which, as an indirect method, yields the free 
fraction or percent free testosterone) coupled to total 
testosterone measurement as described elsewhere (23). 
The symmetric dialysis method correlated well (0.97) 
with the candidate reference measurement procedure 
of free testosterone (24) and measurements in healthy 
males yielded free testosterone results in the range 120 
– 750 pmol/L (24). In this report, the symmetric dialysis 
results were coupled to total testosterone measurements 
by LC-MS/MS, the latter being described elsewhere (25).
Measurement of total testosterone, SHBG, albumin 
and estradiol
SHBG and estradiol (3rd gen) were measured using a 
Roche Cobas8000 (E801) random access analyzer (Roche 
Diagnostics) and albumin were measured using a Roche 
Cobas8000 (C702) random access analyzer using the 
bromocresol purple method. Reference values for SHBG 
(non-pregnant) females: 32–128 nmol/L, for albumin: 
43–55 g/L and for estradiol (ovulatory phase) females: 
151–1460 pmol/L. Intra-assay imprecision was 2.3% at 
10.9 nmol/L and 2.5% at 37.5 nmol/L for SHBG, 3.8% at 
170 pmol/L and 1.1% at 1190 pmol/L for estradiol, 1.2% 
at 25 g/L for albumin, respectively. Total testosterone 
in serum was analyzed by LC-MS/MS after solid phase 
extraction as described by Ter Horst et al. (25)
Calculation of free testosterone
Free testosterone was calculated, based on total 
testosterone, SHBG and albumin with the formula as 
reported by Vermeulen et  al. (13) and the formula as 
reported by Ross et al. (21). In the non-pregnant situation 
the variation in serum albumin is considered negligible 
(13) and therefore a fixed albumin concentration of 
43 g/L is generally used in these formulas. Since pregnant 
women have low albumin levels (20, 26), the calculations 
were performed with the actual albumin levels. To 
investigate the influence of albumin in the formulas 
during pregnancy, calculations were also performed with 
a fixed albumin concentration of 43 g/l.
Statistical analysis
EP Evaluator (David G. Rhoads Associates Inc. 
Consultants, South Burlington, VT, USA; release 12) 
and Excel 2007 (Microsoft, Redmond, WA, USA) were 
used to analyze the data.
Results
Dialysis
The effect of pH and temperature on free testosterone 
was investigated in pool sera with concentrations 
of approximately 80 and 350 pmol/L (n = 4) of free 
testosterone. pH was investigated at 7.30, 7.40 and 7.50 
(at 37°C) and the temperature was investigated at 35.0, 
37.0 and 39.0°C. Free testosterone maximum increase was 
3.4% (at pH 7.30) and −3.5% (at pH 7.50) compared to a 
pH of 7.40. At 35.0°C the free testosterone concentrations 
decreased maximally by 10.7% and at 39.0°C the 
concentrations of free testosterone maximally increased 
by 15.2% compared to dialysis at 37.0°C indicating the 
necessity for accurate temperature during dialysis.
LC-MS/MS
To determine the total imprecision of the free testosterone 
measurement, free testosterone was measured in pool sera 
by ED-LC-MS/MS. At 9, 57 and 254 pmol/L the coefficients 
of variance were subsequently 7.9, 3.4 and 4.0%. The LOQ 
(CV: 10%) was determined at 6 pmol/L. Samples with 
deviations larger than 10%, however, with signal-to-noise 
ratios >10, were quantified according to the calibrators for 
proper statistical processing of data, an example is shown 
in Fig.  1. To investigate the matrix effect of dialysated 
samples after solid phase extraction, ion suppression 
experiments were performed. At a steady infusion of 
testosterone into the MS/MS, three different matrix 
samples after solid phase extraction were injected. The ion 
suppression by the matrix was between 2.9 and 11.8%. 
Figure 1
Chromatogram of free testosterone in a sample of 1 pmol/L  
(i.e. LC-MS/MS measurement in a concentrated solid phase extracted 
dialysate of 5 pmol/L).
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A method comparison with sera from adult males and 
adult females with a validated symmetric dialysis – 
LC-MS/MS method yielded a slope of 1.01 (0.94–1.07); an 
intercept of −0.92 (−4.7 to 2.8) pmol/L and a correlation 
coefficient of 0.99 in a range of 1–300 pmol/L (n = 56). The 
accuracy of the LC-MS/MS method was 96, 94 and 95% at 
79 pmol/L, 114 pmol/L and 225 pmol/L, respectively.
Total and free testosterone measurements
In (non-pregnant) women total testosterone did not exceed 
1.6 nmol/L, consistent with our laboratory reference 
values (adult females 0.5–2.0 nmol/L) and measured free 
testosterone did not exceed 22 pmol/L. In men total 
testosterone was between 2.2 and 30.5 nmol/L, consistent 
with our laboratory reference values (10.5–37.0 nmol/L 
(25)) and free testosterone was measured between 67 
and 454 pmol/L (Fig. 2) in agreement with other reports 
(4, 27, 28, 29). As described by others (30) free testosterone 
concentration declined with age in men. No age-related 
decline in free testosterone levels was observed in women, 
nor a difference between pre- and post-menopausal 
females. Estradiol concentration was highly increased in 
pregnant women, up to 90,000 pmol/L compared to non-
pregnant females. Although in pregnant women the total 
testosterone concentration (mean: 2.1 nmol/L; range: 
0.6–9.0 nmol/L) was higher compared to non-pregnant 
women (mean: 0.6 nmol/L; range: 0.0–1.6 nmol/L; 
P < 0.0001), this was not observed for the free testosterone 
concentration (Fig.  3). On the contrary, the mean free 
testosterone concentration in pregnant women was even 
somewhat lower than that in non-pregnant women (4 vs 
6 pmol/L, respectively, P < 0.002); however, values were in 
the same range (0–19 vs 0–22 pmol/L, respectively). The 
higher concentration of total testosterone in pregnant 
women was not related to the elevated SHBG concentration 
in pregnant women (r = 0.31; range: 91–650 nmol/L).
Comparison of calculated versus measured free 
testosterone levels in pregnant women
Free testosterone was calculated from total testosterone 
and SHBG measurements by the formula of Vermeulen 
et al. (13) or Ross et al. (21).
Calculated free testosterone levels in pregnant women 
were well correlated, but marginally higher, compared 
to measured free testosterone levels with ED-LC-MS/MS 
(formula of Vermeulen et al.: intercept of 2.4 pmol/L and 
slope of 1.06; r = 0.89 and formula of Ross et al. intercept 
of 2.1 pmol/L and slope of 0.91; r = 0.89, respectively). 
Average measured or calculated free testosterone levels 
did not differ in women being 12 or 27 weeks pregnant. 
As shown in Fig. 4, estradiol levels did increase to almost 
90,000 pmol/L in serum of women being 27  weeks 
pregnant, but it did not significantly influence the 
calculations nor the measurements of free testosterone 
levels. Also, no correlation was found between estradiol 
levels and the ratio free testosterone(calculated)/free 
testosterone(measured). With the approach as described 
in Ross et  al. (21) estimates of the testosterone-SHBG 
equilibrium constants (Kd) and the albumin binding 
avidity were made. This estimated Kd of testosterone for 
SHBG did not differ significantly from the values used in 
the calculations. In contrast, the calculations tended to 
underestimate the effect of binding to other binding sites, 
possibly not only albumin.
The decreased albumin value in the pregnant women 
(mean: 32 g/L) was in agreement with earlier reports 
(20, 26). It only marginally influenced the calculations 
of free testosterone. The mean decrease of calculated 
Figure 2
Free testosterone levels in men and women at different ages.
Figure 3
Total testosterone and free testosterone levels in pregnant women  
(12 and 27 weeks of gestation) and non-pregnant women.
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free testosterone in pregnant females with the formula of 
Ross et al. (21) was −0.01 ± 0.01 % (mean ± s.d.), whereas 
with the formula of Vermeulen et al. (13) it was −1.7 ± 0.9% 
when a fixed albumin concentration of 43 g/L was used 
instead of the measured albumin.
Discussion
Increased maternal testosterone concentration during 
pregnancy may lead to fetal growth restriction in utero (7, 
8), disturbance of the insulin–glucose homeostasis (9) and 
possible fetal virilization (10, 11). Therefore it is clinically 
relevant to have a quick and reliable method to determine 
the active (free) testosterone levels. Since measurements 
of free testosterone can only be accurately performed 
with inconvenient dialysis or ultrafiltration techniques to 
separate free from bound hormone (3), formulas reported 
by Vermeulen et al. (13) and Ross et al. (21) are broadly 
used because they make free testosterone quantification 
readily accessible.
However, one has been reluctant to use these formulas 
in premenopausal and especially pregnant women 
due to assumed influence of the increased estradiol on 
the testosterone-binding sites of SHBG as reported by 
Vermeulen et  al. (13). The equilibrium between free 
testosterone concentration, total available protein-
binding sites and total testosterone concentration is 
dependent upon the affinity of testosterone for its binding 
proteins expressed as the dissociation constant Kd.
This estimated Kd is used in the calculation formulas 
to yield a result when total testosterone and SHBG 
concentration are available. The binding affinity of 
estradiol to SHBG is only 3–4 times lower than that of 
testosterone (15, 16) and it has been proposed that 
testosterone and estradiol compete for the SHBG-binding 
sites. Competition of elevated estradiol with testosterone 
for SHBG-binding sites has the same effect as lowering its 
affinity for testosterone (21). Up to now it is assumed that 
in pregnant women the increased estradiol concentration 
gives falsely low calculated free testosterone results, as 
the formulas do not account for this supposed apparent 
decrease in affinity of SHBG for testosterone. Moreover, as 
the calculations fully depend upon the accuracy of total 
testosterone and SHBG estimations, it has been advised 
against using these in women because of well-known 
inaccuracies in total testosterone estimates especially by 
direct immunoassay (21).
If, as recently reported (2, 16, 17, 18) the fraction of 
available SHBG-binding sites (available SHBG-binding 
sites/total SHBG-binding sites) changes when estradiol 
concentration (and SHBG itself) increases and/or estradiol 
binds differently to SHBG than free testosterone, this 
would have an effect on the assumed competitive 
relationship between testosterone and estradiol for SHBG.
We found (marginally) higher calculated free 
testosterone levels, which fully contrasts with the 
concept of falsely low free testosterone calculations in 
pregnant women due to estradiol competition. Moreover 
no significant difference in the affinity of SHBG for 
testosterone could be demonstrated not even at high 
levels of estradiol.
Although measurements with ED-LC-MS/MS better 
approximate the true value of free testosterone, calculated 
free testosterone in pregnant women with either formula 
seems well suitable in clinical practice. The (marginal) 
Figure 4
Free testosterone and estradiol levels in women at 12 and 27 weeks of gestation, arranged per individual in order of increasing estradiol. Free 
testosterone levels are measured with ED-LCMS/MS (green), calculated with the free testosterone formula of Ross et al. (blue) and the formula of 
Vermeulen et al. (red). Estradiol levels are shown as gray bars.
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overestimation of free testosterone by calculation is 
possibly due to a (small) underestimation of albumin or 
other binding proteins in these calculations.
Free testosterone was measured in this study by 
ED-LC-MS/MS. Equilibrium dialysis, and possibly 
ultrafiltration, is considered nowadays the state of the art 
measurement method with potentially minimal chance of 
disturbing the physiological equilibrium with unwanted 
shifts of testosterone from free to bound and vice versa. 
LC-MS/MS enables the direct measurement of testosterone 
concentration. The combination of these two techniques 
enables the accurate quantification of free testosterone. 
Importantly, the equilibrium dialysis should be performed 
under circumstances that minimally disturb the 
physiological equilibrium. For this reason, the dialysis is 
performed under 37.0°C, at a pH of 7.4 and with a dialysis 
buffer that mimics the electrolyte composition of serum 
(22). In agreement with earlier reports that temperature 
of the dialysis should be strictly controlled (13), we 
demonstrate that temperature does influence the free 
testosterone concentration significantly. pH of the buffer 
also influences testosterone binding to SHBG; however, in 
the present study, this effect appeared to be marginal.
Although albumin levels are decreased during 
pregnancy, this did not have a large influence on the 
calculated free testosterone concentration. Since the 
free testosterone formulas mathematically describe 
the testosterone (non)-binding to SHBG and albumin, 
with increasing SHBG concentration the importance of 
albumin as binding protein diminishes in these formulas. 
And therefore, also changes in the albumin concentration 
are of less importance.
The ranges of total and free testosterone found in 
men and women are corresponding with earlier reports 
of measurements with LC-MS/MS (27, 28, 29). As shown 
in Fig.  3 total testosterone is clearly increased during 
pregnancy compared to non-pregnant women and reaches 
levels in the range of male values, while free testosterone 
does not rise and stays in the range of non-pregnant 
women. In our cohort, total testosterone in pregnant 
women even exceeded the value used to diagnose steroid 
cell ovarian tumor in women (>7 nmol/l) (31). This 
underlines the fact that free and not total testosterone 
should be used in (pregnant) women to investigate 
hyperandrogenism (6) or rare steroid cell ovarian tumors. 
Furthermore, it is in full agreement with the clinical 
findings that during a normal pregnancy no physiological 
androgen effects are observed in women.
In conclusion, calculations made with either the 
free testosterone formulas of Ross et  al. (21) or 
Vermeulen  et  al. (13) perform well in pregnant women. 
Calculations of free testosterone in women are not 
affected by estradiol. Moreover, free testosterone and 
not total testosterone should be used to investigate 
hyperandrogenism in pregnant women.
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